domingo, 29 de diciembre de 2019

Clinical trials for next-generation drugs should be patient-centric - STAT

Clinical trials for next-generation drugs should be patient-centric - STAT

First Opinion

Improving the next generation of drugs through patient-centric design for clinical trials

By RICHARD GHALIE


ADOBE
In designing next-generation clinical trials, it is important to emphasize the broader needs of the patients taking part in them.

No hay comentarios:

Publicar un comentario